# CLINRX-ARCH-001 — Long-Term Clinical AI Architecture Standard

**Document ID:** CLINRX-ARCH-001  
**Title:** Long-Term Clinical AI Architecture Standard  
**Version:** 1.0  
**Status:** Draft  
**Effective Date:** 2026-09-24  
**Owner:** ClinRx AI  
**Classification:** Architecture / Foundational Standard  

---

# 1. Purpose

This document defines the long-term architectural principles and system design standards for ClinRx AI.

ClinRx AI is intended to become a trustworthy clinical decision-support platform capable of supporting clinicians with evidence-based, patient-specific clinical reasoning.

The architecture is designed to remain useful and maintainable over a period of at least ten years despite changes in:

- artificial intelligence models
- clinical guidelines
- medical evidence
- drug information
- healthcare workflows
- regulatory requirements
- software technologies
- infrastructure
- interoperability standards

The architecture therefore prioritizes clinical trust, evidence provenance, safety, modularity, auditability, and model independence over rapid feature development.

---

# 2. Vision

ClinRx AI aims to provide clinicians with trustworthy, evidence-grounded, patient-specific clinical decision support.

The core principle is:

> **ClinRx does not replace clinical judgment. It strengthens clinical judgment with structured knowledge, patient context, validated clinical computation, evidence, and AI-assisted reasoning.**

A second architectural principle governs the relationship between AI and the clinical platform:

> **AI reasons. ClinRx governs.**

The AI layer may interpret, synthesize, explain, and communicate information.

The ClinRx platform remains responsible for:

- clinical knowledge
- evidence provenance
- deterministic calculations
- clinical rules
- safety checks
- patient context
- versioning
- auditability
- traceability

---

# 3. Architectural Goals

ClinRx shall be designed to achieve the following goals:

1. Clinical trustworthiness
2. Evidence traceability
3. Patient-specific reasoning
4. Deterministic clinical computation
5. Safe AI integration
6. Model independence
7. Knowledge versioning
8. Full auditability
9. Maintainability
10. Interoperability
11. Scalability
12. Security and privacy
13. Clinical validation
14. Regulatory readiness
15. Long-term technological resilience

---

# 4. Core Architectural Principles

## 4.1 Evidence Before Opinion

ClinRx should preferentially ground clinical recommendations in authoritative and traceable evidence.

Evidence may include:

- clinical guidelines
- regulatory labeling
- peer-reviewed literature
- institutional protocols
- consensus statements
- validated clinical standards
- curated expert knowledge

AI-generated reasoning must not silently become the source of clinical truth.

---

## 4.2 Patient Context Before Recommendation

Clinical recommendations must be interpreted in the context of the individual patient.

Where relevant, ClinRx should consider:

- age
- sex
- weight
- renal function
- hepatic function
- diagnosis
- comorbidities
- allergies
- medications
- laboratory results
- microbiology
- organ support
- CRRT
- ECMO
- transplant status
- procedures
- clinical timeline

A generic recommendation should not be presented as patient-specific advice unless sufficient patient context exists.

---

## 4.3 Deterministic Computation Before AI Estimation

Clinical calculations that can be reliably represented by deterministic algorithms should not depend on an LLM.

Examples include:

- creatinine clearance
- eGFR
- body surface area
- ideal body weight
- adjusted body weight
- corrected sodium
- anion gap
- osmolarity
- MELD
- Child-Pugh
- infusion rates
- renal dose adjustments
- CRRT calculations

AI may explain these results but should not be the authoritative computational engine.

---

## 4.4 Transparency Before Automation

ClinRx should explain the basis of clinically meaningful recommendations.

The system should be able to communicate:

- what it understood
- which knowledge was used
- which evidence was used
- which patient factors mattered
- which calculations were performed
- which safety rules were triggered
- what uncertainty remains

Automation should not reduce transparency.

---

## 4.5 Safety Before Convenience

When a conflict exists between a faster answer and a safer answer, ClinRx should prioritize safety.

ClinRx should prefer:

> "Insufficient information to determine a safe recommendation."

over an unsupported or fabricated recommendation.

---

## 4.6 AI Assists; AI Does Not Own Clinical Truth

The AI model is a reasoning and communication component.

The AI model shall not be treated as the authoritative source of:

- drug doses
- contraindications
- clinical calculations
- guideline versions
- patient facts
- laboratory values
- safety rules

These should originate from controlled ClinRx systems.

---

## 4.7 Model Independence

ClinRx must not become architecturally dependent on a single AI model or provider.

The system should support an abstraction layer capable of interfacing with:

- commercial frontier models
- future foundation models
- specialized medical models
- local models
- institution-hosted models

Changing the AI model should not require redesigning the clinical knowledge architecture.

---

## 4.8 Knowledge Is Versioned

Clinical knowledge must be versioned.

Published knowledge should be immutable.

If knowledge changes:

```text
Version 1.2
    ↓
Retired

Version 1.3
    ↓
Active 